サマリー

炎症性腸疾患の世界市場 2023-2027
炎症性腸疾患市場は、2022-2027年に7687.43百万米ドルの成長が予測され、予測期間中のCAGRは5.77%で加速すると予測されます。この調査レポートは、炎症性腸疾患市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題を掲載し、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、世界的なIBD罹患率の増加、生物学的製剤や標的治療薬に対する需要の増加、IBDに対する意識の高まりによって牽引されています。
Technavio社の炎症性腸疾患市場は以下のように分類されます：
流通チャネル別
- オフライン
- オンライン
タイプ別
- クローン病
- 潰瘍性大腸炎
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間の炎症性腸疾患市場の成長を促進する主な理由の一つとして、IBD治療薬の新規上市を挙げています。また、世界のIBD市場におけるIBD関連研究への資金提供やM&Aは、市場の大きな需要につながるでしょう。
この調査レポートは、炎症性腸疾患市場を調査・分析し、以下の刊行物を刊行しました：
- 炎症性腸疾患市場のサイジング
- 炎症性腸疾患市場の予測
- 炎症性腸疾患市場の産業分析
本レポートでは、炎症性腸疾患市場の主要ベンダー（Abbott Laboratories、AbbVie Inc.、AstraZeneca、Aurobindo Pharma Ltd.、Bausch Health Co.Inc.、Baxter International Inc.、Bayer AG、Biocon Ltd.、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plc、Lupin Ltd.、Merck and Co.Ltd.、Novartis AG、Pfizer Inc.、Sanofi、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Viatris Inc.、Johnson and Johnson Services Inc.また、炎症性腸疾患市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/inflammatory-bowel-disease-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global inflammatory bowel disease market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global inflammatory bowel disease market 2017 - 2021 ($ million)
o 4.2 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.3 Type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Offline - Market size and forecast 2022-2027
o Exhibit 34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Offline - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
o 6.4 Online - Market size and forecast 2022-2027
o Exhibit 38: Chart on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Online - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Online - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Distribution Channel
o Exhibit 42: Market opportunity by Distribution Channel ($ million)
o Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 44: Chart on Type - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Type - Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 46: Chart on Comparison by Type
o Exhibit 47: Data Table on Comparison by Type
o 7.3 Crohn disease - Market size and forecast 2022-2027
o Exhibit 48: Chart on Crohn disease - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Crohn disease - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Crohn disease - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Crohn disease - Year-over-year growth 2022-2027 (%)
o 7.4 Ulcerative colitis - Market size and forecast 2022-2027
o Exhibit 52: Chart on Ulcerative colitis - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Ulcerative colitis - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Ulcerative colitis - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Ulcerative colitis - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Type
o Exhibit 56: Market opportunity by Type ($ million)
o Exhibit 57: Data Table on Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 China - Market size and forecast 2022-2027
o Exhibit 83: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 India - Market size and forecast 2022-2027
o Exhibit 91: Chart on India - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on India - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on India - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on India - Year-over-year growth 2022-2027 (%)
o 9.11 Canada - Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 AstraZeneca
o Exhibit 107: AstraZeneca - Overview
o Exhibit 108: AstraZeneca - Product / Service
o Exhibit 109: AstraZeneca - Key news
o Exhibit 110: AstraZeneca - Key offerings
o 12.4 Aurobindo Pharma Ltd.
o Exhibit 111: Aurobindo Pharma Ltd. - Overview
o Exhibit 112: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 113: Aurobindo Pharma Ltd. - Key offerings
o 12.5 Baxter International Inc.
o Exhibit 114: Baxter International Inc. - Overview
o Exhibit 115: Baxter International Inc. - Business segments
o Exhibit 116: Baxter International Inc. - Key news
o Exhibit 117: Baxter International Inc. - Key offerings
o Exhibit 118: Baxter International Inc. - Segment focus
o 12.6 Bayer AG
o Exhibit 119: Bayer AG - Overview
o Exhibit 120: Bayer AG - Business segments
o Exhibit 121: Bayer AG - Key news
o Exhibit 122: Bayer AG - Key offerings
o Exhibit 123: Bayer AG - Segment focus
o 12.7 Eli Lilly and Co.
o Exhibit 124: Eli Lilly and Co. - Overview
o Exhibit 125: Eli Lilly and Co. - Product / Service
o Exhibit 126: Eli Lilly and Co. - Key news
o Exhibit 127: Eli Lilly and Co. - Key offerings
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 128: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 129: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 130: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 131: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 132: F. Hoffmann La Roche Ltd. - Segment focus
o 12.9 GlaxoSmithKline Plc
o Exhibit 133: GlaxoSmithKline Plc - Overview
o Exhibit 134: GlaxoSmithKline Plc - Business segments
o Exhibit 135: GlaxoSmithKline Plc - Key news
o Exhibit 136: GlaxoSmithKline Plc - Key offerings
o Exhibit 137: GlaxoSmithKline Plc - Segment focus
o 12.10 Johnson and Johnson Services Inc.
o Exhibit 138: Johnson and Johnson Services Inc. - Overview
o Exhibit 139: Johnson and Johnson Services Inc. - Business segments
o Exhibit 140: Johnson and Johnson Services Inc. - Key news
o Exhibit 141: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 142: Johnson and Johnson Services Inc. - Segment focus
o 12.11 Merck and Co. Inc.
o Exhibit 143: Merck and Co. Inc. - Overview
o Exhibit 144: Merck and Co. Inc. - Business segments
o Exhibit 145: Merck and Co. Inc. - Key news
o Exhibit 146: Merck and Co. Inc. - Key offerings
o Exhibit 147: Merck and Co. Inc. - Segment focus
o 12.12 Novartis AG
o Exhibit 148: Novartis AG - Overview
o Exhibit 149: Novartis AG - Business segments
o Exhibit 150: Novartis AG - Key offerings
o Exhibit 151: Novartis AG - Segment focus
o 12.13 Pfizer Inc.
o Exhibit 152: Pfizer Inc. - Overview
o Exhibit 153: Pfizer Inc. - Product / Service
o Exhibit 154: Pfizer Inc. - Key news
o Exhibit 155: Pfizer Inc. - Key offerings
o 12.14 Sanofi
o Exhibit 156: Sanofi - Overview
o Exhibit 157: Sanofi - Business segments
o Exhibit 158: Sanofi - Key news
o Exhibit 159: Sanofi - Key offerings
o Exhibit 160: Sanofi - Segment focus
o 12.15 Sun Pharmaceutical Industries Ltd.
o Exhibit 161: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 162: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 163: Sun Pharmaceutical Industries Ltd. - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 164: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 165: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 168: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Viatris Inc.
o Exhibit 169: Viatris Inc. - Overview
o Exhibit 170: Viatris Inc. - Business segments
o Exhibit 171: Viatris Inc. - Key news
o Exhibit 172: Viatris Inc. - Key offerings
o Exhibit 173: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 174: Inclusions checklist
o Exhibit 175: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 176: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 177: Research methodology
o Exhibit 178: Validation techniques employed for market sizing
o Exhibit 179: Information sources
o 13.5 List of abbreviations
o Exhibit 180: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global inflammatory bowel disease market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Distribution Channel ($ million)
Exhibits43: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits44: Chart on Type - Market share 2022-2027 (%)
Exhibits45: Data Table on Type - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Type
Exhibits47: Data Table on Comparison by Type
Exhibits48: Chart on Crohn disease - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Crohn disease - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Crohn disease - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Crohn disease - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Ulcerative colitis - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Ulcerative colitis - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Ulcerative colitis - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Ulcerative colitis - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Type ($ million)
Exhibits57: Data Table on Market opportunity by Type ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: AstraZeneca - Overview
Exhibits108: AstraZeneca - Product / Service
Exhibits109: AstraZeneca - Key news
Exhibits110: AstraZeneca - Key offerings
Exhibits111: Aurobindo Pharma Ltd. - Overview
Exhibits112: Aurobindo Pharma Ltd. - Product / Service
Exhibits113: Aurobindo Pharma Ltd. - Key offerings
Exhibits114: Baxter International Inc. - Overview
Exhibits115: Baxter International Inc. - Business segments
Exhibits116: Baxter International Inc. - Key news
Exhibits117: Baxter International Inc. - Key offerings
Exhibits118: Baxter International Inc. - Segment focus
Exhibits119: Bayer AG - Overview
Exhibits120: Bayer AG - Business segments
Exhibits121: Bayer AG - Key news
Exhibits122: Bayer AG - Key offerings
Exhibits123: Bayer AG - Segment focus
Exhibits124: Eli Lilly and Co. - Overview
Exhibits125: Eli Lilly and Co. - Product / Service
Exhibits126: Eli Lilly and Co. - Key news
Exhibits127: Eli Lilly and Co. - Key offerings
Exhibits128: F. Hoffmann La Roche Ltd. - Overview
Exhibits129: F. Hoffmann La Roche Ltd. - Business segments
Exhibits130: F. Hoffmann La Roche Ltd. - Key news
Exhibits131: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits132: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits133: GlaxoSmithKline Plc - Overview
Exhibits134: GlaxoSmithKline Plc - Business segments
Exhibits135: GlaxoSmithKline Plc - Key news
Exhibits136: GlaxoSmithKline Plc - Key offerings
Exhibits137: GlaxoSmithKline Plc - Segment focus
Exhibits138: Johnson and Johnson Services Inc. - Overview
Exhibits139: Johnson and Johnson Services Inc. - Business segments
Exhibits140: Johnson and Johnson Services Inc. - Key news
Exhibits141: Johnson and Johnson Services Inc. - Key offerings
Exhibits142: Johnson and Johnson Services Inc. - Segment focus
Exhibits143: Merck and Co. Inc. - Overview
Exhibits144: Merck and Co. Inc. - Business segments
Exhibits145: Merck and Co. Inc. - Key news
Exhibits146: Merck and Co. Inc. - Key offerings
Exhibits147: Merck and Co. Inc. - Segment focus
Exhibits148: Novartis AG - Overview
Exhibits149: Novartis AG - Business segments
Exhibits150: Novartis AG - Key offerings
Exhibits151: Novartis AG - Segment focus
Exhibits152: Pfizer Inc. - Overview
Exhibits153: Pfizer Inc. - Product / Service
Exhibits154: Pfizer Inc. - Key news
Exhibits155: Pfizer Inc. - Key offerings
Exhibits156: Sanofi - Overview
Exhibits157: Sanofi - Business segments
Exhibits158: Sanofi - Key news
Exhibits159: Sanofi - Key offerings
Exhibits160: Sanofi - Segment focus
Exhibits161: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits162: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits163: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits164: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits165: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits166: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits167: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits168: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits169: Viatris Inc. - Overview
Exhibits170: Viatris Inc. - Business segments
Exhibits171: Viatris Inc. - Key news
Exhibits172: Viatris Inc. - Key offerings
Exhibits173: Viatris Inc. - Segment focus
Exhibits174: Inclusions checklist
Exhibits175: Exclusions checklist
Exhibits176: Currency conversion rates for US$
Exhibits177: Research methodology
Exhibits178: Validation techniques employed for market sizing
Exhibits179: Information sources
Exhibits180: List of abbreviations